Safety and efficacy of Razumab – The new biosimilar in India: Our experience

Aim: The aim of this study was to evaluate the safety and efficacy of biosimilar intravitreal ranibizumab (Razumab) for the treatment of chorioretinal vascular diseases such as diabetic macular edema (DME), neovascular age-related macular degeneration (nAMD), and macular edema secondary to retinal v...

Full description

Bibliographic Details
Main Authors: V V Sameera, A G Apoorva, Shrinivas Joshi, A S Guruprasad
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Kerala Journal of Ophthalmology
Subjects:
Online Access:http://www.kjophthal.com/article.asp?issn=0976-6677;year=2016;volume=28;issue=3;spage=180;epage=185;aulast=Sameera